During the past decade, TriState Urologic Services PSC, Inc. conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "TriState Urologic Services PSC, Inc." #1 collaborator was "Allergan" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "TriState Urologic Services PSC, Inc." are "Bladder Cancer" (2 trials), "Bladder Neoplasm" (1 trials), "Carcinoma in Situ" (1 trials), "Interstitial Cystitis" (1 trials) and "Mycobacterium" (1 trials). Many other conditions were trialed in "TriState Urologic Services PSC, Inc." in a lesser frequency.

Most popular intervention types in "TriState Urologic Services PSC, Inc." are "Drug" (3 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Apaziquone" (2 trials), "EN3348" (1 trials), "MN-001" (1 trials) and "MN-001 BID" (1 trials). Other intervention names were less common.

The vast majority of trials in "TriState Urologic Services PSC, Inc." are 4 trials for "All" genders.

Currently, there are NaN active trials in "TriState Urologic Services PSC, Inc.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in TriState Urologic Services PSC, Inc., undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in TriState Urologic Services PSC, Inc., 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".